34.94USD-1.69%Mkt Cap: 2.47B $P/E: —Today
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a prote…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap2.47B $
Enterprise Value2.21B $
Revenue (TTM)100.42M $
Gross Profit41.70M $
Net Income (TTM)-29.82M $
Revenue/Share4.242 USD
Last Price34.94 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees286
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-63.86
PEG—
EV/EBITDA-58.83
EV/Revenue21.96
P/S23.94
P/B7.68
EPS (TTM)-0.70
EPS (Forward)-0.54
52W Range
18.8482% of range38.54
52W High38.54 USD
52W Low18.84 USD
Profitability
Gross Margin56.20%
Oper. Margin-45.98%
EBITDA Margin-37.33%
Profit Margin-40.18%
ROE18.76%
ROA-21.30%
Growth
Revenue Growth82.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-53.61M $
CapEx (TTM)6.38M $
FCF Margin—
FCF Yield—
Net Debt-198.65M $
Net Debt/EBITDA5.30
Balance Sheet
Debt/Equity-0.26
Current Ratio11.85
Quick Ratio9.67
Book Value/Sh4.509 USD
Cash/Share3.603 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)33.40 USD
Upside (mean)-4.4%
Target Range31.00 USD – 35.00 USD
$31.00-4.4% to mean$35.00
# Analysts5
Ownership
Shares Out.69.39M
Float36.16M
Insiders26.64%
Institutions58.10%
Short Interest
Short Ratio9.3d
Short % Float5.68%
Short % Out.3.50%
Shares Short2.43M
Short (prev mo.)2.79M
Technical
SMA 5026.58 (+31.4%)
SMA 20024.79 (+41.0%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)287.86K
Avg Vol (10d)442.45K
Technical Indicators
RSI (14)68.4
MACD2.3591
MACD Signal1.7062
MACD Hist.+0.6529
BB Upper36.38 USD
BB Middle28.57 USD
BB Lower20.76 USD
BB Width54.68%
ATR (14)2.575 USD
Vol Ratio (20d)1.93x